EIP
BIVV

Epoch Investment Partners’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Epoch Investment Partners’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-24,287
Closed -$1.31M – 327
2017
Q4 		$1.31M Buy
24,287
+174
+0.7% +$9.52K ﹤0.01% 278
2017
Q3 		$1.38M Buy
24,113
+200
+0.8% +$11.7K ﹤0.01% 279
2017
Q2 		$1.44M Buy
+23,913
New +$1.36M ﹤0.01% 276

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Epoch Investment Partners's BIVV Position: Q1 2018 in Review

Epoch Investment Partners sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 24,287 shares — an estimated $1.31M sold.

Epoch Investment Partners first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $1.44M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Epoch Investment Partners reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Epoch Investment Partners sold 24,287 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1.31M.
  • Epoch Investment Partners first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
  • Epoch Investment Partners's Bioverativ Inc. Common Stock position peaked at $1.44M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Epoch Investment Partners's 13F filing for Q1 2018, filed 14 May 2018.